Monopar Therapeutics
Nasdaq · Healthcare · Pharmaceutical Preparations · Wilmette, IL
MNPR chart
What traders are saying about $MNPR
Latest postsMonopar Therapeutics news
- BlackRock reports 338,133 shares in Monopar Therapeutics (MNPR).
Stock Titan ·
- Responsive Playbooks and the MNPR Inflection
Stock Traders Daily ·
- Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Oric Pharmaceuticals (ORIC)
The Globe and Mail ·
- Monopar Therapeutics Inc Estimates – DUS:1IY0
TradingView ·
- MNPR falls as seller pressure persists
Traders Union ·
- Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026
Yahoo Finance ·
- Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
Yahoo Finance ·
- Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
Yahoo Finance ·
- Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team
Yahoo Finance ·
- Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease
Yahoo Finance ·
- Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
Yahoo Finance ·
- Wall Street Analysts Believe Monopar Therapeutics (MNPR) Could Rally 88.92%: Here's is How to Trade
Yahoo Finance ·
Monopar Therapeutics key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | – | – |
| Net income | -$13.7M | -$15.6M | -$8.4M | -$10.5M |
| Total assets (year end) | $140.7M | $60.3M | $7.3M | $13.2M |
| Cash and equivalents (year end) | $61.8M | $45.8M | $7.3M | $8.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Monopar Therapeutics
- Ticker
- MNPR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wilmette, IL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1645469
Frequently asked questions
What exchange is Monopar Therapeutics listed on?
Monopar Therapeutics trades on the Nasdaq under the ticker symbol MNPR.
What industry is Monopar Therapeutics in?
Monopar Therapeutics is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Monopar Therapeutics headquartered?
Monopar Therapeutics's business address on file with the SEC is in Wilmette, IL.
When does Monopar Therapeutics's fiscal year end?
Monopar Therapeutics's fiscal year ends on December 31.
How much revenue did Monopar Therapeutics report?
Monopar Therapeutics reported $0 in revenue for calendar year 2025, according to its SEC filings.